We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+9.45%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$428B
AUM Growth
-$10.7B
Cap. Flow
-$22.3B
Cap. Flow %
-5.22%
Top 10 Hldgs %
27.96%
Holding
16,128
New
3,614
Increased
5,201
Reduced
5,802
Closed
1,312

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$913M
2
META icon
Meta Platforms (Facebook)
META
+$659M
3
CAT icon
Caterpillar
CAT
+$450M
4
PYPL icon
PayPal
PYPL
+$435M
5
BDX icon
Becton Dickinson
BDX
+$348M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$860M
2
HUM icon
Humana
HUM
+$581M
3
GS icon
Goldman Sachs
GS
+$372M
4
BSX icon
Boston Scientific
BSX
+$345M
5
WMT icon
Walmart Inc
WMT
+$327M

Sector Composition

Rank Sector Weight
1 Technology 3.36%
2 Healthcare 2.87%
3 Financials 2.57%
4 Consumer Discretionary 2.23%
5 Industrials 2.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DAO
13776
PUT
Youdao
DAO
$2.17B
$6.99K ﹤0.01%
+1,300
New +$5.64K
AKA icon
13777
CALL
a.k.a. Brands
AKA
$118M
$6.99K ﹤0.01%
+458
New +$9.12K
APEN
13778
PUT
DELISTED
Apollo Endosurgery, Inc.
APEN
$6.98K ﹤0.01%
700
-14,400
-95% -$107K
NUVL
13779
DELISTED
Nuvalent
NUVL
$6.97K ﹤0.01%
234
-40,231
-99% -$1.12M
SYRE icon
13780
Spyre Therapeutics
SYRE
$9.14B
$6.96K ﹤0.01%
619
-1,812
-75% -$32.6K
GAME icon
13781
CALL
GameSquare
GAME
$42.7M
$6.96K ﹤0.01%
+1,775
New +$5.53K
LYEL icon
13782
PUT
Lyell Immunopharma
LYEL
$342M
$6.94K ﹤0.01%
+100
New +$9.93K
OPRA
13783
CALL
Opera Ltd
OPRA
$1.82B
$6.92K ﹤0.01%
1,100
-13,800
-93% -$69.4K
SXC icon
13784
PUT
SunCoke Energy
SXC
$794M
$6.9K ﹤0.01%
+800
New +$6.18K
PGRU
13785
PUT
DELISTED
PropertyGuru Group Limited
PGRU
$6.9K ﹤0.01%
1,600
-17,300
-92% -$83.7K
BSQR
13786
PUT
DELISTED
BSQUARE Corporation
BSQR
$6.89K ﹤0.01%
+6,100
New +$6.74K
ANGO icon
13787
CALL
AngioDynamics
ANGO
$655M
$6.88K ﹤0.01%
+500
New +$6.96K
OTMO
13788
PUT
DELISTED
Otonomo Technologies Ltd. Ordinary shares
OTMO
$6.88K ﹤0.01%
1,147
-1,673
-59% -$8.99K
LXRX icon
13789
PUT
Lexicon Pharmaceuticals
LXRX
$1.03B
$6.88K ﹤0.01%
+3,600
New +$7.66K
FLNT
13790
PUT
Fluent
FLNT
$129M
$6.87K ﹤0.01%
+1,050
New +$7.71K
MZZ icon
13791
CALL
ProShares UltraShort MidCap400
MZZ
$2.3M
$6.85K ﹤0.01%
+400
New +$7.02K
CUE icon
13792
PUT
Cue Biopharma
CUE
$144M
$6.84K ﹤0.01%
+80
New +$7.32K
ZYME icon
13793
Zymeworks
ZYME
$1.78B
$6.83K ﹤0.01%
869
-122,458
-99% -$861K
GHSI
13794
DELISTED
Guardion Health Sciences, Inc. Common Stock
GHSI
$6.8K ﹤0.01%
+937
New +$7.5K
NHTC icon
13795
PUT
Natural Health Trends
NHTC
$15.5M
$6.8K ﹤0.01%
+2,000
New +$7.62K
SYRE icon
13796
CALL
Spyre Therapeutics
SYRE
$9.14B
$6.79K ﹤0.01%
604
ALGS icon
13797
CALL
Aligos Therapeutics
ALGS
$43M
$6.77K ﹤0.01%
+284
New +$7.16K
CLS icon
13798
PUT
Celestica
CLS
$42.3B
$6.76K ﹤0.01%
+600
New +$6.31K
ARCE
13799
PUT
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
$6.75K ﹤0.01%
+500
New +$5.61K
IHRT icon
13800
PUT
iHeartMedia
IHRT
$457M
$6.74K ﹤0.01%
1,100
-17,700
-94% -$136K

Similar funds

Ken Griffin's Q4 2022 Portfolio in Review

As of Q4 2022, Ken Griffin held 16,128 positions worth $428B, down 2.4% from $439B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin withdrew a net $22.3B in Q4 2022, closing 1,312 positions and reducing 5,802 holdings. Its most notable exit was Twitter, Inc., an estimated $297M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.4% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Ken Griffin opened a new position in Denbury Inc. worth $107M.

  • Ken Griffin's largest Q4 2022 buy was Denbury Inc.: 1,228,903 shares worth $107M.
  • Ken Griffin added most to Tesla in Q4 2022, an estimated $913M increase.
  • Ken Griffin's biggest Q4 2022 reduction was Amazon, cutting an estimated $860M.
  • Ken Griffin fully exited Twitter, Inc. in Q4 2022, selling an estimated $297M.
  • Ken Griffin's ten largest holdings make up 28% of its $428B portfolio in Q4 2022.
  • Ken Griffin opened 3,614 new positions and closed 1,312 in Q4 2022.
  • Ken Griffin's portfolio value fell 2.4% quarter-over-quarter to $428B.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.